International Journal of Dermatology, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 29, 2025
In this paper, the European Academy of Dermatology and Venereology (EADV) Task Force on Quality Life (QoL) Patient-Oriented Outcomes presents its position statements health-related (HR) QoL assessment in epidermolysis bullosa (EB). The EADV TF recommends use EB-specific instrument QOLEB patients over age 10 years and, addition to QOLEB, iscorEB-p moderate-to-severe EB; IntoDermQoL proxy with module should be used children aged under 5 years. iscorEB-p, dermatology-specific CDLQI may measure HRQoL EB from Dermatology-specific and/or generic instruments compare impact other diseases; family studied using EB-BoD, measures, instruments.
Language: Английский